[ad_1]
According to Laura Bielskė, head of communication for Eurovaistinė, when the pandemic started, there was a discussion about what would happen if certain preparations were not received in time.
“It was a pre-quarantine period in which many people were unable to return from the invited countries.” This issue has been addressed at the European level and the creation of the economic corridor has achieved what we ordered, “he said.
According to Mindaugas Urbas, head of marketing and communication at Benu Pharmacy Network, there are drug supply disruptions, but there are no clear trends to highlight any specific category or drug.
“It is difficult to say that the COVID-19 pandemic is the cause of drug supply disruptions, as there are often many variables in the production, logistics and ordering chains,” he told BNS.
It is true that a representative of Benu Pharmacy pointed out that the State Drug Control Service has recently begun to announce temporary and permanent interruptions in the supply of drugs and planned dates for the resumption of supply.
“Perhaps this can be seen as a sign that there is a growing public need for information on the drug supply situation and possible disruptions quickly and easily,” Urbas said.
There were also no drug shortages due to the coronavirus in the Amber Pharmacy and Norfa Pharmacy networks.
“We work with providers around the world, but there are currently no major disruptions that affect stable work and pose a threat to patients. At the beginning of the pandemic, there was concern among producers about possible interruptions in the supply of raw materials, but the supply chains have maintained the necessary stability and we can say that all producers and suppliers are prepared. We have also done our homework, securing stocks of the most popular drugs, ”said Gerald Kauneckas, pharmacy representative.
According to Žiedūnė Juškytė, director of the communication project of the Nemuno vaistinė company, which runs Camelia pharmacies, there have also been no interruptions in the supply of medicines due to the pandemic.
“There are only normal interruptions in the supply of some medicines for other reasons, such as the quotas applied to Lithuania,” he said.
All pharmacies recognize that certain supply disruptions occur on a regular basis, as patients’ medications are no longer manufactured, their packaging, dosages or suppliers change, new registration is delayed, and other reasons. The outages can continue for half a year.
Some pharmacy employees have even admitted that they face at least one case almost daily when they do not have the drug they want to buy or the drug prescribed by a doctor.
Afroditė Berūkštienė, an employee of Ramun Ramlė Pharmacy in Kaunas, emphasized that drug-related disorders are more frequently recorded at the turn of the year, in December and January.
